Evidence map›Paper›PMID 39723564›Full record

ArticleBiometrics2024

Semi-parametric sensitivity analysis for trials with irregular and informative assessment times.

Bonnie B Smith, Yujing Gao, Shu Yang, Ravi Varadhan, Andrea J Apter, Daniel O Scharfstein

Abstract read
In one paragraph

Article in Biometrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bonnie B SmithDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States.ORCID 0000-0001-6211-8432
Yujing GaoDepartment of Statistics, North Carolina State University, Raleigh, NC 27695, United States.
Shu YangDepartment of Statistics, North Carolina State University, Raleigh, NC 27695, United States.ORCID 0000-0001-7703-707X
Ravi VaradhanDepartment of Oncology, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States.ORCID 0000-0002-8434-1034
Andrea J ApterPulmonary Allergy Critical Care Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.
Daniel O ScharfsteinDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84108, United States.ORCID 0000-0001-7482-9653

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI ALAN KEITH MEEKER · 1985 to 2026
$208.6M
A Patient Advocate to improve real-world asthma management for inner city adultsR18HL116285 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI APTER, ANDREA J. · 2013 to 2017
$3.6M
Statistical methods for structural and functional integration in multi-modal neuroimaging dataR01EB029977 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI CAFFO, BRIAN SCOTT · 2021 to 2024
$1.9M
Missing Data Matters: Substance Use Disorder Clinical TrialsR01DA046534 · NIDA · UNIVERSITY OF UTAH · PI SCHARFSTEIN, DANIEL OSCAR · 2018 to 2020
$1.4M
National Science Foundation SES 2242776NCI NIH HHS P30 CA006973NHLBI NIH HHS R18 HL116285NIBIB NIH HHS R01 EB029977NIDA NIH HHS R01 DA046534NIH HHS EB029977Patient-Centered Outcomes Research Institute ME-2021C3-24972
6 · The paper itself

Abstract

Many trials are designed to collect outcomes at or around pre-specified times after randomization. If there is variability in the times when participants are actually assessed, this can pose a challenge to learning the effect of treatment, since not all participants have outcome assessments at the times of interest. Furthermore, observed outcome values may not be representative of all participants' outcomes at a given time. Methods have been developed that account for some types of such irregular and informative assessment times; however, since these methods rely on untestable assumptions, sensitivity analyses are needed. We develop a sensitivity analysis methodology that is benchmarked at the explainable assessment (EA) assumption, under which assessment and outcomes at each time are related only through data collected prior to that time. Our method uses an exponential tilting assumption, governed by a sensitivity analysis parameter, that posits deviations from the EA assumption. Our inferential strategy is based on a new influence function-based, augmented inverse intensity-weighted estimator. Our approach allows for flexible semiparametric modeling of the observed data, which is separated from specification of the sensitivity parameter. We apply our method to a randomized trial of low-income individuals with uncontrolled asthma, and we illustrate implementation of our estimation procedure in detail.

Indexed as

AsthmaModels, StatisticalRandomized Controlled Trials as TopicBiometryComputer SimulationData Interpretation, StatisticalHumansOutcome Assessment, Health CarePovertyTime Factorsasthmaexplainable assessmentinfluence functioninverse intensity weightingsemi-parametric estimation

Identifiers

PMID39723564
PMCPMC11669851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.